The Biomarker Battlefield: CTCs vs. cfDNA

добавлена новая статья Health

2025-10-14 11:33:25 - Перевод

The Biomarker Battlefield: CTCs vs. cfDNA – Which Segment is Dominating the Technological Advancements in the Liquid Biopsy Market?

The **liquid biopsy market** is best viewed as a biomarker battlefield, primarily contested between two dominant molecular entities: circulating tumor cells (CTCs) and cell-free DNA (cfDNA), of which circulating tumor DNA (ctDNA) is a key component. CTCs, intact tumor cells shed into the bloodstream, offer a comprehensive view of the tumor's biology, including its protein expression, cellular...

0 Комментарии 0 Поделились 193 Просмотры 0 предпросмотр